| Paul Cespedes, MD | |
|
7777 Forest Ln Ste C865, Dallas, TX 75230 | |
| (972) 566-3431 | |
| (972) 566-3142 |
| Full Name | Paul Cespedes |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 14 Years |
| Location | 7777 Forest Ln Ste C865, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689994956 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | A125487 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Plano | Plano, TX | Hospital |
| Texas Health Presbyterian Hospital Denton | Denton, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Questcare Hospitalists Pllc | 5799785119 | 318 |
News Archive
How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today's most pressing health issues.
For the second year in a row, Hospital for Special Surgery is the only hospital in New York State with an infection rate that is significantly lower than the state average for hip replacement or revision surgeries, according to the 2009 report on hospital infection rates released today by the State Department of Health.
New insight on the molecular mechanisms that allow malaria parasites to move and spread disease within their hosts has been published today in the open-access eLife journal.
PEAK Surgical, Inc. and Medtronic, Inc. (NYSE: MDT) today announced an agreement that grants the Surgical Technologies business at Medtronic exclusive rights for global distribution and marketing of the PEAK PlasmaBlade® TnA (Tonsil and Adenoid) tissue dissection device for the ear, nose, and throat (ENT) market.
A device designed at the University of Pittsburgh could help improve outcomes as a treatment for COVID-19 when used in conjunction with non-invasive or mechanical ventilation, and it recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration.
› Verified 6 days ago
| Entity Name | Questcare Hospitalists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today's most pressing health issues.
For the second year in a row, Hospital for Special Surgery is the only hospital in New York State with an infection rate that is significantly lower than the state average for hip replacement or revision surgeries, according to the 2009 report on hospital infection rates released today by the State Department of Health.
New insight on the molecular mechanisms that allow malaria parasites to move and spread disease within their hosts has been published today in the open-access eLife journal.
PEAK Surgical, Inc. and Medtronic, Inc. (NYSE: MDT) today announced an agreement that grants the Surgical Technologies business at Medtronic exclusive rights for global distribution and marketing of the PEAK PlasmaBlade® TnA (Tonsil and Adenoid) tissue dissection device for the ear, nose, and throat (ENT) market.
A device designed at the University of Pittsburgh could help improve outcomes as a treatment for COVID-19 when used in conjunction with non-invasive or mechanical ventilation, and it recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Cespedes, MD 7777 Forest Ln Ste C865, Dallas, TX 75230-6884 Ph: (972) 566-3431 | Paul Cespedes, MD 7777 Forest Ln Ste C865, Dallas, TX 75230 Ph: (972) 566-3431 |
News Archive
How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today's most pressing health issues.
For the second year in a row, Hospital for Special Surgery is the only hospital in New York State with an infection rate that is significantly lower than the state average for hip replacement or revision surgeries, according to the 2009 report on hospital infection rates released today by the State Department of Health.
New insight on the molecular mechanisms that allow malaria parasites to move and spread disease within their hosts has been published today in the open-access eLife journal.
PEAK Surgical, Inc. and Medtronic, Inc. (NYSE: MDT) today announced an agreement that grants the Surgical Technologies business at Medtronic exclusive rights for global distribution and marketing of the PEAK PlasmaBlade® TnA (Tonsil and Adenoid) tissue dissection device for the ear, nose, and throat (ENT) market.
A device designed at the University of Pittsburgh could help improve outcomes as a treatment for COVID-19 when used in conjunction with non-invasive or mechanical ventilation, and it recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration.
› Verified 6 days ago
Uma B.r.k Pakkivenkata, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |